comparemela.com

Latest Breaking News On - Glaukos company profile - Page 6 : comparemela.com

Insider Selling: Glaukos Co (NYSE:GKOS) CFO Sells $52,784 82 in Stock

Insider Selling: Glaukos Co (NYSE:GKOS) CFO Sells $52,784 82 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

84,605 Shares in Glaukos Co (NYSE:GKOS) Acquired by Lisanti Capital Growth LLC

84,605 Shares in Glaukos Co (NYSE:GKOS) Acquired by Lisanti Capital Growth LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Glaukos (NYSE:GKOS) PT Raised to $105 00

Glaukos (NYSE:GKOS – Free Report) had its price objective increased by Piper Sandler from $90.00 to $105.00 in a research note issued to investors on Friday morning, Benzinga reports. The firm currently has an overweight rating on the medical instruments supplier’s stock. Other equities research analysts also recently issued research reports about the stock. Stifel […]

Glaukos Co (NYSE:GKOS) Given Average Recommendation of Moderate Buy by Brokerages

Glaukos Co. (NYSE:GKOS – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eleven ratings firms that are presently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 1-year price objective […]

Glaukos (NYSE:GKOS) Sets New 52-Week High at $81 85

Glaukos Co. (NYSE:GKOS – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $81.85 and last traded at $81.26, with a volume of 418750 shares traded. The stock had previously closed at $81.24. Analysts Set New Price Targets A number of brokerages have commented […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.